Farobin A, a natural compound, exhibits antibacterial, antioxidant, and anti-inflammatory properties. It is effective against Streptococcus mutans ATCC 25175 and Streptococcus sobrinus ATCC 33478. Additionally, Farobin A demonstrates anti-inflammatory activity by targeting cytokine IL-6 and TNF-α [1].

Farobin A (compound 3) demonstrates moderate antibacterial activity at a concentration of 100 μg/mL against Streptococcus mutans ATCC 25175 (inhibition rate of 28%) and Streptococcus sobrinus ATCC 33478 (inhibition rate of 26%) [1]. In RAW264.7 cells, Farobin A at 100 μg/mL reduces IL-6 production from 2463.9 pg/mL (LPS stimulated) to 1051.8 pg/mL, and decreases TNF-α production from 14,644.8 pg/mL (LPS stimulated) to 9606 pg/mL when treated under the same concentration [1].